Global prevalence of celiac disease: systematic review and meta-analysis

P Singh, A Arora, TA Strand, DA Leffler… - Clinical …, 2018 - Elsevier
Background & Aims Celiac disease is a major public health problem worldwide. Although
initially it was reported from countries with predominant Caucasian populations, it now has …

Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis

S Singh, AN Sharma, MH Murad, NS Buttar… - Clinical …, 2013 - Elsevier
Background & Aims Central adiposity has been implicated as a risk factor for Barrett's
esophagus (BE) and esophageal adenocarcinoma (EAC), possibly promoting the …

[HTML][HTML] European guideline on obesity care in patients with gastrointestinal and liver diseases–Joint ESPEN/UEG guideline

SC Bischoff, R Barazzoni, L Busetto… - Clinical Nutrition, 2022 - Elsevier
Background Patients with chronic gastrointestinal (GI) disease such as inflammatory bowel
disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux …

Role of overweight and obesity in gastrointestinal disease

S Emerenziani, M Pier Luca Guarino, LM Trillo Asensio… - Nutrients, 2019 - mdpi.com
The prevalence of obesity is increasing worldwide, leading to a severe impairment of overall
health. Actually, obesity has been associated with several pathological conditions, causing …

Influence of obesity on the risk of esophageal disorders

J Lagergren - Nature reviews Gastroenterology & hepatology, 2011 - nature.com
Obesity is associated with an increased risk of esophageal disorders, including esophageal
adenocarcinoma, Barrett esophagus and GERD. For reasons yet unknown, the association …

Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study

HB El-Serag, A Hashmi, J Garcia, P Richardson… - Gut, 2014 - gut.bmj.com
Objective Abdominal obesity has been associated with increased risk of Barrett's
oesophagus (BE) but the underlying mechanism is unclear. We examined the association …

European guideline on obesity care in patients with gastrointestinal and liver diseases–Joint European Society for Clinical Nutrition and Metabolism/United European …

SC Bischoff, R Barazzoni, L Busetto… - United European …, 2022 - Wiley Online Library
Background Patients with chronic gastrointestinal (GI) disease such as inflammatory bowel
disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux …

A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH–AARP Diet and Health Study

MG O'Doherty, ND Freedman, AR Hollenbeck… - Gut, 2012 - gut.bmj.com
Objective The incidence of oesophageal adenocarcinoma (EAC) has increased rapidly over
the past 40 years and accumulating evidence suggests that obesity, as measured by body …

Practical guideline on obesity care in patients with gastrointestinal and liver diseases–Joint ESPEN/UEG guideline

SC Bischoff, J Ockenga, A Eshraghian, R Barazzoni… - Clinical Nutrition, 2023 - Elsevier
Background Patients with chronic gastrointestinal disease such as inflammatory bowel
disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux …

[HTML][HTML] Obesity-related digestive diseases and their pathophysiology

SY Nam - Gut and liver, 2017 - ncbi.nlm.nih.gov
Obesity is a growing medical and public health problem worldwide. Many digestive diseases
are related to obesity. In this article, the current state of our knowledge of obesity-related …